Terminal bladder tumours mostly seed later tumours
A Nature autopsy series reconstructed 104 tumours from 20 patients and found metastasis-to-metastasis seeding as the dominant spread pattern. News Medical, sourced to Fred Hutchinson Cancer Center, quotes Gavin Ha that metastasis is the major driver of death from bladder cancer in this programme.
Science··Morning
104 tumours from 20 rapid autopsies
News Medical, dated 16 September 2026 and sourced to Fred Hutchinson Cancer Center, says a Nature study reconstructed 104 tumors from 20 patients at Fred Hutch and the University of Washington and found metastatic tumors seeded new metastases. Gavin Ha is quoted that metastasis is the major driver of death from bladder cancer. Andrew Hsieh says metastases may be the staging point for disease to spread. The rapid autopsy program also involved Ming Lam and Omar Mian. The journal reference is Itagi et al., Nature 2026, DOI 10.1038/s41586-026-11035-z.[2]
The cohort is terminal disease, not incidence
The peer-reviewed Nature autopsy series reconstructs terminal metastatic bladder cancer and finds metastasis-to-metastasis seeding as the dominant spread pattern; polyclonal migration tracked with poorer prognosis in this cohort. The programme is observational and enriched for histological subtypes in people who already had terminal disease, so it does not measure incidence in earlier bladder cancer. Plasmacytoid and neuroendocrine variants carried early driver changes tied to shorter survival in this set. Mutational signatures indicated plasmacytoid tumours using the Fanconi anaemia pathway against chemotherapy scarring.[1]
Seeding is the pattern in this autopsy set
News Medical's 104-tumour, 20-patient count and the Nature series describe the same rapid-autopsy reconstruction. Metastasis-to-metastasis seeding is the dominant pattern here; the Nature paper warns the design does not measure how often that happens in earlier, non-terminal bladder cancer. Post-mortem cell-free DNA captured subtype heterogeneity without, by itself, making cfDNA a screening test.[2], [1]
